Xencor (XNCR) Other Working Capital Changes (2013 - 2026)
Xencor (XNCR) reported Other Working Capital Changes of $2.4 million for Q1 2026, up 750.0% year-over-year from $281411.8 in Q1 2025, and down 72.7% quarter-over-quarter from $8.8 million in Q4 2025.
Xencor (XNCR) Other Working Capital Changes (2013 - 2026) Analysis & Trends
Xencor (XNCR) has 14 years of Other Working Capital Changes data on file, last reported at $2.4 million in Q1 2026.
- Other Working Capital Changes for Q1 2026 came in at $2.4 million, up 750.0% year-over-year; the trailing twelve-month figure through Mar 2026 was $2.8 million (up 90.74% YoY), and the FY2024 annual result was -$159000.0, up 96.88% from the prior year.
- Other Working Capital Changes slipped to $2.4 million in Q1 2026 per XNCR's latest filing, from $8.8 million in the prior quarter.
- Over five years, Other Working Capital Changes peaked at $8.8 million in Q4 2025 and troughed at -$5.3 million in Q3 2025.
- A 5-year average of -$579058.8 and a median of -$465000.0 in 2023 frame the typical range for Other Working Capital Changes.
- The sharpest annual moves came in 2024 and 2025: Other Working Capital Changes slumped 1025.81% in 2024, then jumped 5084.02% in 2025.
- A 5-year view of Other Working Capital Changes shows it stood at -$4.9 million in 2022, then gained by 27.85% to -$3.5 million in 2023, then soared by 104.81% to $169000.0 in 2024, then jumped by 5084.02% to $8.8 million in 2025, then plunged by 72.7% to $2.4 million in 2026.
- Business Quant data shows XNCR's Other Working Capital Changes at $2.4 million in Q1 2026, $8.8 million in Q4 2025, and -$5.3 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Xencor | 953.38 Mn | 878.64 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.39 Mn |
| Mar 31, 2026 | 2.39 Mn |
| Dec 31, 2025 | 8.76 Mn |
| Dec 31, 2025 | 8.76 Mn |
| Sep 30, 2025 | -5.26 Mn |
| Sep 30, 2025 | -5.26 Mn |
| Jun 30, 2025 | -3.14 Mn |
| Jun 30, 2025 | -3.14 Mn |
| Mar 31, 2025 | -368,000.00 |
| Mar 31, 2025 | -368,000.00 |
| Dec 31, 2024 | 169,000.00 |
| Dec 31, 2024 | 169,000.00 |
| Sep 30, 2024 | -5.24 Mn |
| Sep 30, 2024 | -5.24 Mn |
| Jun 30, 2024 | 6.88 Mn |
| Jun 30, 2024 | 6.88 Mn |
| Mar 31, 2024 | -1.97 Mn |
| Mar 31, 2024 | -1.97 Mn |
| Dec 31, 2023 | -3.51 Mn |
| Dec 31, 2023 | -3.51 Mn |